Collegium Pharmaceutical (COLL) Competitor Comparison
We are evaluating the key criteria listed to compare Collegium Pharmaceutical (COLL) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
21 / 54Gross Profits
15 / 39Total Revenue
21 / 50EBITDA
11 / 53Free Cashflow
7 / 54Quick Ratio
37 / 54Earnings per Share
3 / 54Dividend yield
0 / 5Total Cash
11 / 54Performance 3 years
6 / 54Performance 5 years
7 / 54Performance 10 years
5 / 54Linearity 3 years
20 / 54Linearity 5 years
17 / 54Linearity 10 years
50 / 54Total Rank
32 / 54Dividend Rank
13 / 54Valuation Rank
20 / 54Piotroski Rank
18 / 54Muliplier Rank
38 / 54EBITDA - COLL ranking 11 / 53
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.